Literature DB >> 21960240

[Pharmacotherapy for preventing calcium containing stone formation].

Masao Nagata1, Tatsuya Takayama, Souichi Mugiya, Seiichiro Ohzono.   

Abstract

Many urinary tract stones consist of calcium, and has high relapse rate. Accordingly, it is very important to prevent calcium-containing stone formation. This paper describes about effects and mechanisms for Xanthine oxidase inhibitor, citrate formulation, magnesium formulation, thiazides, vitamin B(6), extract of Quercus salicina Blume and chorei-to (medical herb) . Recent new drugs and the elucidation of new metabolic pathways may lead to the development of prevention of urolithiasis.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21960240     DOI: CliCa111015301534

Source DB:  PubMed          Journal:  Clin Calcium        ISSN: 0917-5857


  2 in total

1.  The protective effects of an herbal agent tutukon on ethylene glycol and zinc disk induced urolithiasis model in a rat model.

Authors:  Emrah Yuruk; Murat Tuken; Cahit Sahin; Asuman Orcun Kaptanagasi; Kayhan Basak; Serdar Aykan; Ahmet Yaser Muslumanoglu; Kemal Sarica
Journal:  Urolithiasis       Date:  2016-05-09       Impact factor: 3.436

2.  Anti-Inflammatory and Anti-Urolithiasis Effects of Polyphenolic Compounds from Quercus gilva Blume.

Authors:  Sung Hye Youn; Joo Hee Kwon; Jun Yin; Le Thi Tam; Hye Shin Ahn; Soon Chul Myung; Min Won Lee
Journal:  Molecules       Date:  2017-07-05       Impact factor: 4.411

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.